Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution.

Ritter MR, Moreno SK, Dorrell MI, Rubens J, Ney J, Friedlander DF, Bergman J, Cunningham BB, Eichenfield L, Reinisch J, Cohen S, Veccione T, Holmes R, Friedlander SF, Friedlander M.

Lymphat Res Biol. 2003;1(4):291-9.

PMID:
15624557
2.

Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis.

Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7455-60.

3.

Immune response: A possible role in the pathophysiology of hemangioma.

Sun ZJ, Zhao YF, Zhang WF.

Med Hypotheses. 2007;68(2):353-5. Epub 2006 Sep 25.

PMID:
16997493
4.

Myeloid cells in infantile hemangioma.

Ritter MR, Reinisch J, Friedlander SF, Friedlander M.

Am J Pathol. 2006 Feb;168(2):621-8.

5.

Biomolecular markers and involution of hemangiomas.

Frischer JS, Huang J, Serur A, Kadenhe A, Yamashiro DJ, Kandel JJ.

J Pediatr Surg. 2004 Mar;39(3):400-4.

PMID:
15017560
6.

Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.

Nguyen VA, Kutzner H, Fürhapter C, Tzankov A, Sepp N.

Mod Pathol. 2006 Feb;19(2):291-8.

7.

Mesenchymal stem cells and adipogenesis in hemangioma involution.

Yu Y, Fuhr J, Boye E, Gyorffy S, Soker S, Atala A, Mulliken JB, Bischoff J.

Stem Cells. 2006 Jun;24(6):1605-12. Epub 2006 Feb 2.

8.

Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.

Calicchio ML, Collins T, Kozakewich HP.

Am J Pathol. 2009 May;174(5):1638-49. doi: 10.2353/ajpath.2009.080517. Epub 2009 Apr 6.

9.

Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas.

Jia J, Zhao YF, Zhao JH.

Med Hypotheses. 2007;68(2):288-90. Epub 2006 Sep 28.

PMID:
17010532
10.

Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis.

Chang J, Most D, Bresnick S, Mehrara B, Steinbrech DS, Reinisch J, Longaker MT, Turk AE.

Plast Reconstr Surg. 1999 Jan;103(1):1-9; discussion 10.

PMID:
9915157
11.

Growth characteristics of infantile hemangiomas: implications for management.

Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Nopper AJ, Frieden IJ; Hemangioma Investigator Group.

Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767.

PMID:
18676554
12.

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ.

Nat Med. 2003 Oct;9(10):1269-74. Epub 2003 Sep 21.

PMID:
14502282
13.

Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma.

North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC Jr.

Arch Dermatol. 2001 Dec;137(12):1607-20.

PMID:
11735711
14.

[A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].

Van den Eynde B.

Bull Mem Acad R Med Belg. 2003;158(7-9):356-63; discussion 364-5. French.

PMID:
15132006
16.
17.

Congenital hemangiomas.

Boull C, Maguiness SM.

Semin Cutan Med Surg. 2016 Sep;35(3):124-7. doi: 10.12788/j.sder.2016.045. Review.

PMID:
27607320
18.

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM.

Blood. 2005 Feb 15;105(4):1574-81. Epub 2004 Oct 5.

19.

Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.

Rafice SA, Chauhan N, Efimov I, Basran J, Raven EL.

Biochem Soc Trans. 2009 Apr;37(Pt 2):408-12. doi: 10.1042/BST0370408. Review.

PMID:
19290871
20.

Supplemental Content

Support Center